These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 18070717)

  • 21. [The importance of autologous transplantation in multiple myeloma].
    Pour L; Hájek R; Adam Z; Krejcí M; Vorlícek J
    Vnitr Lek; 2009 Sep; 55(9):767-72. PubMed ID: 19785373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of newly diagnosed myeloma.
    Rajkumar SV; Palumbo A
    Hematol Oncol Clin North Am; 2007 Dec; 21(6):1141-56, ix-x. PubMed ID: 17996592
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stem-cell transplantation for multiple myeloma in the era of novel drugs.
    Bensinger W
    J Clin Oncol; 2008 Jan; 26(3):480-92. PubMed ID: 18056678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of multiple myeloma in the targeted therapy era.
    Saad AA; Sharma M; Higa GM
    Ann Pharmacother; 2009 Feb; 43(2):329-38. PubMed ID: 19193585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short-term thalidomide incorporated into double autologous stem-cell transplantation improves outcomes in comparison with double autotransplantation for multiple myeloma.
    Cavo M; Di Raimondo F; Zamagni E; Patriarca F; Tacchetti P; Casulli AF; Volpe S; Perrone G; Ledda A; Ceccolini M; Califano C; Bigazzi C; Offidani M; Stefani P; Ballerini F; Fiacchini M; de Vivo A; Brioli A; Tosi P; Baccarani M
    J Clin Oncol; 2009 Oct; 27(30):5001-7. PubMed ID: 19720903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of high-dose therapy with autologous stem cell support in the era of novel agents.
    Attal M; Harousseau JL
    Semin Hematol; 2009 Apr; 46(2):127-32. PubMed ID: 19389496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hematopoietic stem cell transplantation in multiple myeloma.
    Pant S; Copelan EA
    Biol Blood Marrow Transplant; 2007 Aug; 13(8):877-85. PubMed ID: 17640590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stem-cell transplantation in multiple myeloma.
    Harousseau JL; Moreau P; Attal M; Facon T; Avet-Loiseau H
    Best Pract Res Clin Haematol; 2005; 18(4):603-18. PubMed ID: 16026740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Consolidation therapy with low-dose thalidomide and prednisolone prolongs the survival of multiple myeloma patients undergoing a single autologous stem-cell transplantation procedure.
    Spencer A; Prince HM; Roberts AW; Prosser IW; Bradstock KF; Coyle L; Gill DS; Horvath N; Reynolds J; Kennedy N
    J Clin Oncol; 2009 Apr; 27(11):1788-93. PubMed ID: 19273705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple myeloma: chemotherapy or transplantation in the era of new drugs.
    Palumbo A; Rajkumar SV
    Eur J Haematol; 2010 May; 84(5):379-90. PubMed ID: 20345446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autologous hematopoietic stem-cell transplantation for multiple myeloma.
    Harousseau JL; Moreau P
    N Engl J Med; 2009 Jun; 360(25):2645-54. PubMed ID: 19535803
    [No Abstract]   [Full Text] [Related]  

  • 32. Multiple myeloma.
    Harousseau JL; Shaughnessy J; Richardson P
    Hematology Am Soc Hematol Educ Program; 2004; ():237-56. PubMed ID: 15561686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conventional therapy and approach to management.
    Rajkumar SV; Kyle RA
    Best Pract Res Clin Haematol; 2005; 18(4):585-601. PubMed ID: 16026739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simple variables predict survival after autologous transplantation: a single centre experience in 181 multiple myeloma patients.
    Krejci M; Hajek R; Buchler T; Krivanova A; Svobodnik A; Pour L; Adam Z; Mayer J; Vorlicek J
    Neoplasma; 2007; 54(2):143-8. PubMed ID: 17319788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of autologous transplantation for acute myeloid leukemia in first and second remission.
    Linker C
    Best Pract Res Clin Haematol; 2007 Mar; 20(1):77-84. PubMed ID: 17336257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Symptom burden after autologous stem cell transplantation for multiple myeloma.
    Campagnaro E; Saliba R; Giralt S; Roden L; Mendoza F; Aleman A; Cleeland C; Weber D; Brown J; Anderson KO
    Cancer; 2008 Apr; 112(7):1617-24. PubMed ID: 18260091
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The allogeneic dilemma.
    Harousseau JL
    Bone Marrow Transplant; 2007 Dec; 40(12):1123-8. PubMed ID: 17680016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autologous transplantation in elderly patients with multiple myeloma: are we asking the right questions?
    Klepin HD; Hurd DD
    Bone Marrow Transplant; 2006 Nov; 38(9):585-92. PubMed ID: 16953209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stem cell transplantation in multiple myeloma.
    Attal M; Moreau P; Avet-Loiseau H; Harousseau JL
    Hematology Am Soc Hematol Educ Program; 2007; ():311-6. PubMed ID: 18024645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of new treatment approaches in defining treatment goals in multiple myeloma--the ultimate goal is extended survival.
    Durie BG
    Cancer Treat Rev; 2010 May; 36 Suppl 2():S18-23. PubMed ID: 20472184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.